Podcasts about Cochlear

Cochlear implants are neat little devices that drastically improve one's quality of life. However, only about 10% of those that qualify for cochlear implants have actually received one. When one thinks of cochlear implants, the first thing that might come to mind is surgery--invasive, lengthy, with a long time of recovery. However, at PNI, patients can expect a much faster, minimally invasive treatment option. Dr. Rebecca Lewis, the Audiology Director of the Adult & Pediatric Cochlear Implant Program, highlights the importance of getting an evaluation done, and early. Studies have shown that the earlier one gets treatment for their hearing issues, the better the outcome. Mathilde Tranberg, an outreach and patient support specialist at PNI, is a cochlear implant recipient herself. As she was implanted as a child, she knows firsthand how helpful it can be. Her goal is to spread the word about cochlear implants through community outreach and education. Listen in and learn about how these innovative devices are changing lives.

For today's episode of Buy or Sell, Adam Keily is joined by Roger Montgomery, Founder of Montgomery Investment Management.If you want to hear more from Adam Keily, make sure you check our Comedian v Economist (Apple | Spotify)—------Want to get involved in the podcast? Record a voice note or send us a message—------Want more Equity Mates? Across books, podcasts, video and email, however you want to learn about investing - we've got you covered.Keep up with the news moving markets with our daily newsletter and podcast (Apple | Spotify)Check out our latest show: Basis Points (Apple | Spotify | YouTube) and read the accompanying Basis Points email—------Looking for some of our favourite research tools?Read our free ETF Investing HandbookDownload our free 4-step stock checklistFind company information on TIKRScreen the market with GuruFocusTrack your portfolio with Sharesight—------In the spirit of reconciliation, Equity Mates Media and the hosts of Equity Mates Investing acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people today.—------Equity Mates Investing is a product of Equity Mates Media.This podcast is intended for education and entertainment purposes. Any advice is general advice only, and has not taken into account your personal financial circumstances, needs or objectives. Before acting on general advice, you should consider if it is relevant to your needs and read the relevant Product Disclosure Statement. And if you are unsure, please speak to a financial professional.Equity Mates Media operates under Australian Financial Services Licence 540697. Hosted on Acast. See acast.com/privacy for more information.

Following the record high of yesterday and the strong performances over the week the market has paused for breath today and lost some steam as the day went on. Laura and Stevie discuss the slight dip in US markets overnight despite positive trade talks and consumer inflation data that was heading in the right direction, and what could be keeping markets cautious. Monash was in focus again today after news of a resignation, and Cochlear recovered most of the losses that it saw early in the session. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

With consumers in the United States really starting to feel the pinch of tariffs, luxury goods retailers like Cettire could see the pain on their balance sheets sooner rather than later. MARKET WRAP: ASX200: up 0.31%, 8,565 GOLD: $3,360 US/oz BITCOIN: $166,138 AUD Monash IVF CEO Michael Knaap announced his resignation. Shares up 9.1% Cochlear downgraded its guidance, but the market sent the company 0.7% higher to $272.31. Telstra, Transurban, and Coles were all higher. Cettire fell more than 30% after its CEO warned the market of weaker demand from US customers. AGL suffered a swing against it of 0.9% after confirming it could sell its stake in Tilt Renewables. Myer lost 0.7% Sliding more than 1% was BHP, Macquarie, and Goodman. CURRENCY UPDATE: AUD/USD: 64.9 US cents AUD/GBP: 47.9 pence AUD/EUR: 56 Euro cents AUD/JPY: 93 Japanese yen AUD/NZD: 1.07 NZ dollars See omnystudio.com/listener for privacy information.

Cochlear implants can improve hearing for patients with severe hearing loss. Join Dr. Gerry Clancy and Dr. Alexander Claussen as they discuss how cochlear implants function, how to determine which patients are candidates, and recent advances in the technology. CME Credit Available:  https://uiowa.cloud-cme.com/course/courseoverview?P=0&EID=xxxxx  Host: Gerard Clancy, MD Senior Associate Dean for External Affairs Professor of Psychiatry and Emergency Medicine University of Iowa Carver College of Medicine Guest: Alexander D. Claussen, MD Assistant Professor of Otolaryngology/Neurotology University of Iowa Carver College of Medicine Financial Disclosures:   Dr. Claussen has disclosed the following relevant financial relationship: iotaMotion, Inc. - sponsored research Dr. Clancy and the members of the Rounding@IOWA planning committee have disclosed no relevant financial relationships. Relevant financial relationships have been mitigated. Nurse: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this activity for a maximum of 0.5 ANCC contact hour. Pharmacist: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this knowledge-based activity for a maximum of 0.5 ACPE contact hours. Credit will be uploaded to the NABP CPE Monitor within 60 days after the activity completion. Pharmacists must provide their NABP ID and DOB (MMDD) to receive credit. Pharmacist UAN: JA0000310-0000-25-070-H01-P   Pharmacy Tech UAN: JA0000310-0000-25-070-H01-T Physician: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other Health Care Providers: A certificate of completion will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.) References/Resources:  American Cochlear Implant Alliance Task Force Guidelines for Determining Cochlear Implant Candidacy in Children https://pubmed.ncbi.nlm.nih.gov/35213891/ American Cochlear Implant Alliance Task Force: Recommendations for Determining Cochlear Implant Candidacy in Adults https://pubmed.ncbi.nlm.nih.gov/37435829/  

Cochlear implants remain vastly underutilized despite decades of evidence showing their ability to restore hearing and improve quality of life. In this episode, neurotologist Dr. Varun Varadarajan joins host Brian Taylor to explore the clinical, logistical, and cultural barriers that continue to limit access to cochlear implant care. Drawing on his background in music and neuroscience, Dr. Varadarajan shares his journey into hearing restoration surgery and offers insights into early intervention, the 60/60 referral guideline, and why timing matters for long-term outcomes.The discussion highlights several misconceptions that often delay or prevent patients from seeking cochlear implant evaluation—from concerns about age, surgery, and cost to misunderstandings about candidacy and device function. Dr. Varadarajan stresses the importance of individualized counseling, collaborative decision-making, and helping patients understand that cochlear implantation is a process, not a one-size-fits-all solution. He also addresses myths within the professional community, including hesitancy around residual hearing loss and outdated assumptions about surgical complexity.Beyond clinical considerations, Dr. Varadarajan shares practical strategies for building and expanding cochlear implant programs, including the importance of audiology partnerships, reimbursement planning, and aligning institutional goals. He also explains the value of the Cochlear Provider Network in connecting rural or underserved patients to implant services, and discusses how remote care and virtual follow-up are reshaping postoperative management.Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn and X (formerly Twitter). https://twitter.com/WeekinHearing- https://www.linkedin.com/company/this-week-in-hearing- https://hearinghealthmatters.org/thisweek/

The American Red Cross begins sending teams of volunteers to go to homes to assess flood damage, Buffalo Trace Distillery slowly getting back to business after historic floooding, and Louisville boy talks about life after being the first in the U.S. to receive a new type of cochlear implant. 

In this episode, host Mitch Robbins interviews Mickey Brown, Vice President of Access and Reimbursement at Cerapedics, discussing his 30+ year career journey and insights on healthcare market access.Key Highlights:Mickey shares his transition from 15 years on the payer side (Blue Cross, United Healthcare) to manufacturer roles at Medtronic, Cochlear, and now CerapedicsLearn how stepping outside his comfort zone at critical moments propelled his career forwardDiscover the biggest challenges facing market access professionals in 2025Understand common reimbursement strategy mistakes companies make and how to avoid themPractical Takeaways:Why waiting too long to develop reimbursement strategy hurts product launchesThe key differences between director and VP-level thinkingWhat makes an outstanding market access professionalHow to effectively engage with increasingly inaccessible payersWhether you're in medical device sales, reimbursement, or aspiring to leadership roles in healthcare, this conversation offers valuable insights from both sides of the healthcare ecosystem.

The world's largest market, the US, started the new trading week mostly in the green despite investors remaining nervous about ‘liberation day' on April 2nd whereby it is expected President Donald Trump will announce an array of reciprocal tariffs on countries he believes have been tough on the US in terms of tariffs and trade in recent years. The Dow Jones rose 1%, the S&P500 added 0.55% and the tech-heavy Nasdaq ended the day down 0.14%.In Europe overnight the sea of red extended into the new trading week across the region as investors brace for reciprocal tariffs out of the US on 2nd April. The STOXX600 fell 1.51% to post the first losing month on the index for 2025. Germany's DAX lost 1.33%, the French CAC fell 1.58% and, in the UK, the FTSE100 ended the day down 0.88%.Across the APAC region on Monday, markets also closed lower on Monday ahead of Trump's second round of tariffs to be announced. Japan's Nikkei plunged 4.05%, China's CSI index lost 0.71%, Hong Kong's Hang Seng fell 1.09% and South Korea's Kospi index ended the day down 3%.South Korea and Japan are expected to bear much of the brunt of Trump's newly introduced 25% automotive tariff with these regions ranking 2nd and 3rd among the countries with the highest automotive trade with the US.Locally to start the week the ASX200 plunged into the red with a 1.7% decline at the closing bell to mark the 3rd worst trading session of the year, as global market sentiment remains uneasy amid escalated tariff, trade war and subdued economic global growth concerns.The iron ore mining giants were sold off on Monday as the outlook for exports remains murky, especially to our largest trade partner, China. BHP, Rio and Champion Iron each fell over 3%, over 4% and over 5% respectively to start the new trading week lower.Domain shares fell almost 2% on Monday after the board unanimously recommended a takeover bid from US real estate company CoStar to shareholders. Shareholders were seemingly unimpressed which led to the sell-off yesterday.What to watch today:Ahead of Tuesday's trading session the ASX, the SPI futures are anticipating the market will open the day up 0.85% tracking Wall Street's gains overnight.The all-important RBA interest rate meeting is today with the market expecting Australia's central bank to hold the current cash rate at 4.1% for the next period.On the commodities front this morning, oil is trading 2.85% higher at US$71.34/barrel, gold is 1.3% higher at US$3124/ounce and iron ore is up 0.07% at US$102.43/tonne.The Aussie dollar has weakened against the greenback overnight to buy US$0.62, 93.67 Japanese Yen, 48.22 British Pence and NZ$1.10.Trading Ideas:Bell Potter has slightly reduced the 12-month price target on Light & Wonder (ASX:LNW) from $205 to $197 and maintain a buy rating on the leading global cross-platform games operator after Aristocrat Leisure escalated its legal fight against Light and Wonder with a second amended complaint around LNW's Jewel of the Dragon game.And Trading Central has identified a bearish signal on Cochlear (ASX:COH) following the formation of a pattern over a period of 23-days which is roughly the same amount of time the share price may fall from the close of $262.30 to the range of $246 to $250 according to standard principles of technical analysis.

A deeper understanding of how the brain regulates sound perception through inner ear nerve fibers could transform the way hearing loss is diagnosed and managed. In this conversation, Dr. John Oghalai explores groundbreaking research that uncovers the brain's role in modulating cochlear nerve fibers to adjust sound levels in response to hearing loss. These findings provide new insights into auditory processing and may help explain conditions such as hyperacusis and tinnitus, offering potential pathways for future treatment approaches.Dr. Oghalai further explores the implications of these findings for future treatments and personalized hearing care. He also shares how advanced imaging technologies like optical coherence tomography (OCT) could one day revolutionize the diagnosis and management of hearing disorders, potentially leading to more effective and tailored therapeutic approaches. This discussion provides a detailed look at the evolving landscape of hearing research and its potential impact on patient care.Learn more about the work being conducted in Dr. Oghalai's lab: https://oghalailab.usc.edu/research/Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn and X (formerly Twitter).- https://twitter.com/WeekinHearing- https://www.linkedin.com/company/this-week-in-hearing

Miss South Africa Mia Le Roux Dr. Helene Basson Jackie from The Dis-Chem Foundation See omnystudio.com/listener for privacy information.

The local market closed 0.2% higher on Friday, buoyed by a strong rally for the consumer staples sector amid strong results out of TWE and investors buying up the supermarket giants on Friday. For the week, the ASX posted a gain of 0.52% as industrials and the consumers stocks rallied, while healthcare stocks took a 3.75% hit over the 5-trading days.Reporting season ramped up on Friday with Avita Medical soaring 11% after the company announced a guidance range of $158m to $167m for commercial revenues in 2025, while GQG rose 5.9% after doubling net inflows to the half year to December.Hearing device specialist Cochlear on the other hand fell 13% on Friday after downgrading profit guidance for FY25 due to weaker services contribution and increased cloud-related investment, despite the company posting a 5% rise in sales in H1 to $1.17bn.In the US on Friday, markets closed mixed on Friday despite investors gaining certainty around Trump's tariff plans and fresh economic data signalling the US inflation story is not running hot as was previously feared. The Dow Jones fell 0.4%, the S&P500 fell just 0.01% and the Nasdaq ended the day up 0.41%. For the week, each of the major averages posted a gain. The latest US inflation reading out last week showed core inflation rose more than expected in January by 0.4% MoM, and 3.3% YoY, while the overall inflation rate rose to 3% YoY, while retail sales in the US fell 0.9% in January MoM, which was more of a decline than the markets were expecting.Across the European region on Friday, markets pulled back from record highs earlier in the week. The STOXX fell 0.24%, Germany's DAX lost 0.44%, the French CAC rose 0.18%, and, in the UK, the FTSE100 ended the day down 0.37%.Asia markets closed mixed on Friday as investors assessed President Trump's reciprocal tariff plans but did not enact levies immediately. China's CSI index rose 0.87%, Hong Kong's Hang Seng rose 3.48%, South Korea's Kospi Index gained 0.31%, and Japan's Nikkei fell 0.79%.What to watch today:Ahead of Monday's session on the ASX, the SPI futures are anticipating the local market will open the day down 0.61%.On the commodities front this morning, oil is trading 0.77% lower at US$70.74/barrel, gold is down 1.73% at US$2880.76/ounce and iron ore is up 0.06% at US$106.83/tonne.The Aussie dollar has strengthened against the greenback to buy US$0.63, 96.63 Japanese Yen, 50.47 British Pence and NZ$1.11.On the reporting season calendar today, Aurizon, Bendigo and Adelaide Bank, BlueScope Steel, Lendlease Group and A2 Milk will release results.Trading Ideas:Bell Potter has upgraded Pro Medicus (ASX:PME) from a hold to a buy rating and have increased the 12-month price target on the leading diagnostic imaging healthcare provider following the release of the company's first half results. Despite PME reporting a small miss on earnings, the outlook remains strong and with 10 contract announcements and strong growth in the cardiology space expected, the analyst sees strong upside potential for the company in H2.And Trading Central has identified a bullish signal on Endeavour Group (ASX:EDV) following the formation of a pattern over a period of 52-days which is roughly the same amount of time the share price may rise from the close of $4.42 to the range of $4.68 and $4.74 according to standard principles of technical analysis.

SBS Finance Editor Ricardo Gonçalves speaks with Cochlear CEO Dig Howitt following the hearing implant maker's profit result on the company's future and US experience; plus Omkar Joshi from Opal Capital Management takes a look at the day on the sharemarke

SBS Finance Editor Ricardo Gonçalves speaks with Cochlear CEO Dig Howitt following the hearing implant maker's profit result on the company's future and US experience; plus Omkar Joshi from Opal Capital Management takes a look at the day on the sharemarke

Technology stocks are leading the market higher despite ongoing inflation concerns, with Nvidia rising on strong chip demand and Apple shares gaining ahead of a new product launch on February 19. US bond yields have dropped after producer price data signaled easing inflation, while MGM Resorts saw its biggest jump since 2020. Meanwhile, AppLovin is emerging as a potential rival to TikTok. In commodities, oil steadied after paring losses on tariff hopes, but iron ore declined due to Indian tax concerns. Gold, on the other hand, rose in response to Trump’s tariff plans. Looking ahead, Aussie shares are expected to open higher on Friday ahead of key earnings reports from Cochlear and Mirvac. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

The ASX is home to some very long-term performers in the healthcare sector - think CSR and Cochlear - as well as some more recent arrivals.Steve Wheen, Managing Director, Equity Research at Jarden, talks to Sean Aylmer about the opportunities he sees within healthcare stocks in Australia.This is Fear & Greed's summer investing series. All information is general in nature - you should seek independent professional advice before making investment decisions.Find out more: https://fearandgreed.com.auSee omnystudio.com/listener for privacy information.

The ASX is home to some very long-term performers in the healthcare sector - think CSR and Cochlear - as well as some more recent arrivals.Steve Wheen, Managing Director, Equity Research at Jarden, talks to Sean Aylmer about the opportunities he sees within healthcare stocks in Australia.This is Fear & Greed's summer investing series. All information is general in nature - you should seek independent professional advice before making investment decisions.Support the show: http://fearandgreed.com.auSee omnystudio.com/listener for privacy information.

Lou zeroes in on another self-diagnosis for his mysterious hearing loss and recounts Sebadoh's, first in five years, show in Seattle. Many names are dropped, Adelle is there to pick them up. Also, Lou plays another lo-fi demo for a possible Dinosaur Jr song, Adelle says it's good! watch it on LouTubehttps://youtu.be/Kb4z-mNerTwjoin our Substack!https://substack.com/@barlowfamilygeneral Hosted on Acast. See acast.com/privacy for more information.

Host Christine Blackburn hosts a solo episode about her hearing loss, cochlear implant surgery, and one of her best friends passing away. Listen to Story Worthy anywhere you hear your podcasts! Each week Hollywood's most talented people in the entertainment industry share true, personal stories on the Story Worthy Podcast. Story Worthy celebrates 14 years of podcasting in July 2024 and has over 800 episodes recorded. Christine Blackburn is the creator, host and producer of Story Worthy, Story Smash the Storytelling Game Show, and My Life In 3 Songs exclusively on Spotify. Listen to the entire episode wherever you hear podcasts. If you get a chance, will you please give Story Worthy 5 stars and a good review on Apple Podcasts? It always helps, thank you! And join the mailing list!  Follow Christine's new show, My Life In 3 Songs. Independent Podcast Producer Christine Blackburn talks to comedians about the 3 songs in their lives that have impacted them, not necessarily their favorite songs, but songs that paint a picture of the of the comedian and where they're from. Listen exclusively on Spotify Find My Life In 3 Songs on Insta and at the website ! PLUS! Watch Story Smash The Storytelling Game Show! Comedians spin a wheel and tell TRUE 1-3 minute stories on the topic they land. You can watch episodes from the pandemic and from summer 2023 right now on YouTube. See Story Smash LIVE at the Lyric/Hyperion Theater in Los Angeles now! Check the website for upcoming dates and tickets! And here's Christine  everywhere. THANK YOU!

Radio show host, Gary Calligas will have Gauri Mankekar, MD, PhD with Ochsner LSU Health in Shreveport and Ms. Brooke Collins, Clinical Audiologist with Ochsner LSU Health in Shreveport on his Saturday, November 23rd “The Best of Times Radio Hour” at 9:05 AM on News Radio 710 KEEL to discuss hearing loss and the benefit of implanted hearing devices, like Cochlear implants. You can also listen to this radio talk show streaming LIVE on the internet at www.710KEEL.com. and streaming LIVE on 101.7 FM or via the KEEL app on apple and android devices. For more information, please visit these websites at www.thebestoftimesnews.com and www.hebertstandc.com. This radio show is proudly presented by AARP Louisiana and Hebert's Town and Country of Shreveport featuring – Dodge, Chrysler, Ram, and Jeep vehicles and service.

The team address founders, Cochlear and the value of field trips.See omnystudio.com/listener for privacy information.

Imagine a world without sound. No laughter, no music. Cochlear implants are now increasingly covered by insurance in China, suddenly making the unattainable attainable for many. We explore the impact of this change in healthcare policy and learn more about the benefits the patients may enjoy. On the show: Heyang, Steve Hatherly & Yushun

Aussie stocks rebounded today with the ASX200 up by roughly a third of a percent, nearing a record high, despite some midday fading. Mining and energy sectors led the charge, fuelled by hopes for Chinese stimulus and Rio Tinto's $10 billion acquisition of Arcadium Lithium, its biggest deal in 17 years. Lithium miners surged, with Arcadium's shares up 39% and optimism spreading across the sector. In the US, all eyes are on inflation data, which could influence upcoming interest rate decisions. Meanwhile, companies like Netwealth and Cochlear made gains on positive updates and dividend payments.   The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

Hurricane Milton is ripping the US east coast apart, but could it have an impact on ASX listed companies in the insurance building space. MARKET WRAP: ASX200: up 0.44%, 8,223 GOLD: $2,633 US/oz BITCOIN: $93,887 AUD BHP rose 1.4% to $43.90 and lithium producer Pilbara Minerals closed up 2.4% to $2.92. Some of the smaller miners such as Lake Resources jumped 11% and Liontown resources closed up 5% to 83 cents. Rio Tinto also had a good day closing up 1.3% to $119.87, but was helped by its deal to acquire Arcadium Lithium.  Shares in Arcadium rose by 38% to $8.20.. On the other side of the coin was Cochlear which has dropped around 17% in recent months from its all time high and today fell 1.55% to $290.43. CURRENCY UPDATE: AUD/USD: 67.28 US cents AUD/GBP: 52.3 pence AUD/EUR: 62 Euro cents AUD/JPY: 100 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

The stimulus that many thought would come from China hasn't appeared, sending global markets backwards today. MARKET WRAP: ASX200: down 0.35% to 8,176 GOLD: $2,655 US/oz BITCOIN: $93,739 AUD CSL had a healthy day up just under 1 ½ per cent to $292.52, with Cochlear nearby, closing up by 0.6% to $293.43  After a turbulent few weeks in the aviation space Qantas closed up 1% to to $7.13 Macquarie Bank is likely to benefit from US rate cuts supporting confidence in global M & A activity shares up to $229.58  And West African resources bounced back after falling 20% yesterday to close up 7% to $1.44 Iron ore futures backwards to $US 107 a tonne, hampering our local miners Aristocrat Leisure stocks were sold off late in the day, down to $57.74 CURRENCY UPDATE: AUD/USD: 67.27 US cents AUD/GBP: 51.4 pence AUD/EUR: 61 Euro cents AUD/JPY: 99 Japanese yen AUD/NZD: 1.09 NZ dollars See omnystudio.com/listener for privacy information.

Guest: Melissa Anderson, AuD, CCC-A: This episode explores cochlear nerve deficiency (CND) and its consequences, focusing on using cochlear implants in this population. The guest provides expert insights into counseling and programming, as well as what collaborating on a team to manage these patients looks like.

In today's episode, we sit down with Liza McKelvey, VP of People and Culture at Cochlear, to discuss the impact of prioritising employee wellbeing in a time of crisis and beyond. Liza shares how her team embraced our framework during the pandemic's toughest days, turning it into a long-term strategy that still resonates across cultures and teams today.We explore the importance of tailored approaches to wellbeing, why a one-size-fits-all method doesn't work, and how fostering a culture of care can transform workplace dynamics. If you're curious about making a meaningful investment in your team's wellbeing, you won't want to miss Liza's insights on finding creative, impactful ways to support your people—even when budgets are tight.Here are the highlights:(1:45) Challenges Faced During the Pandemic (3:20) Framework and Energy Management Tools (5:15) Justifying the Investment in Well-being Programs (7:16) Ease of Working with Aurora (11:24) Personal Stories and Impact of Aurora Take the Aurora 360 Quiz: How Effective Is Your Company's Wellbeing Strategy? Click HereConnect with us here:Website: aurorawellnessgroup.co.ukLinkedIn: NgoziLinkedIn: ObehiAurora Company Profile 2024Book a Call here

The first Harris-Trump debate is about to take place, but will we learn anything on the pair's economic credentials? MARKET WRAP: ASX200: up 0.30% to 8,011 AUD: 66.58 US cents GOLD: $2,530 US/oz BITCOIN: $85,807 AUD Fission Uranium Corp shareholders voted in favour for a takeover, with Paladin shares up 5.9% to $8.86 Commonwealth hit another all-time high at $143.77, and Westpac & NAB up at seven-year highs.  Also up by more than 1% was QBE, Suncorp and Resmed – helped by that news on Apple's alerts for sleep apnoea. Steadfast Group dropping almost 11% after ABC reporting into strata practices Life 360 fell by 8.1% to $17.03 after a pullback on its US-listed shares overnight. Also in the red was Fortescue, Brambles and Cochlear. CURRENCY UPDATE: AUD/USD: 66.58 US cents AUD/GBP: 50.9 pence AUD/EUR: 60 Euro cents AUD/JPY: 95 Japanese yen AUD/NZD: 1.08 NZ dollars See omnystudio.com/listener for privacy information.

Another big day for corporate reports in Australia – among those headlining, Telstra and hearing implant supplier Cochlear. Rena Sarumpaet speaks with its CEO Dig Howitt about the results. Plus what the latest data says about Australia's economy – and what's causing the miners to slide. For more, Rhayna Bosch speaks to MPC markets head of trading Jonathan Tacadena.

The Australian share market is teetering on a fifth consecutive day of modest gains despite a mixed bag of economic data. A surprising surge in job growth saw 58,200 new jobs in July, driving speculation about potential rate cuts, though uncertainty lingers. In the corporate world, Cochlear shares plunged over 7% despite solid profits, while Telstra's shares rose on news of a dividend increase, despite a dip in profits. Notable moves included Treasury Wine Estates benefiting from easing Chinese tariffs, and Pilbara Minerals acquiring Latin Resources, sending Latin's shares soaring.     The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

Cochlear is putting faith that the demand for implants will continue, with sales revenue & net profit up across 2023-24.See omnystudio.com/listener for privacy information.

Australia's unemployment rate grows to 4.2%; US inflation trending in the right direction; Telstra adds customers to its mobile network; Cochlear forecasts continued demand; car reselling unaffected by an economic slowdown; a boost for media & advertising thanks to the Olympics; and company reporting continues in the Market Wrap. Host: Deb Knight Executive Producer: Tom Storey Technical Producer: Liam Achurch Publisher: Nine RadioSee omnystudio.com/listener for privacy information.

In a session from Future of Field Service Live in Cologne, Germany, host Sarah Nicastro welcomes back Daniel Trabel, Director of Field Service EMEA at Thermo Fisher Scientific, to discuss how critical a company's talent strategy is to service today and why it demands creativity and a willingness to break free of the status quo to be successful. Daniel is a passionate and visionary leader with a strong track record in clinical diagnostics, life sciences, medical devices, and biotechnology. Before joining Thermo Fisher Scientific, he was a Service Manager at Waters Corporation in Germany South, served as a Service Engineer at Cochlear, and held various key positions at Bio-Rad Laboratories. If you enjoyed this episode, make sure to subscribe, rate, and review on Apple Podcasts, Spotify, and Google Podcasts. Also, subscribe to our newsletter right here: https://www.futureoffieldservice.com/the-insider

In this episode of "I'm Just Dizzy," we delve into a topic that has garnered significant attention over recent years: the prevalence of vestibular and cochlear symptoms associated with COVID-19 infections and vaccinations. Join us as we unravel the complexities behind symptoms such as dizziness, tinnitus, and hearing loss, which have become notably common among COVID-19 survivors and those who have been vaccinated.We start by exploring the statistics that shed light on the frequency of these symptoms. Post-COVID-19 infection, a significant number of people have exhibited spontaneous and positional nystagmus, difficulty with eye movements, and vertigo, indicating potential inner ear damage and vestibular dysfunction. We also discuss the incidence of these symptoms following vaccination, reassuring listeners that while the numbers are lower, the experiences of those affected are no less significant.Our journey continues as we examine the potential causes of these symptoms. From direct viral infections of the inner ear to vascular complications and the impact of Long COVID, we cover the various factors contributing to these distressing conditions. We delve into the intricacies of inner ear infections, such as vestibular neuritis and labyrinthitis, and their potential to lead to chronic conditions like Persistent Postural Perceptual Dizziness (3PD).Moreover, we address the challenges in diagnosing central vestibular disorders and the importance of an accurate diagnosis for effective treatment. Highlighting the benefits of vestibular rehabilitation and complementary therapies, we emphasize the need for individualized treatment plans to aid recovery.Finally, we stress the importance of ongoing research in understanding these symptoms and developing better treatment protocols. As we wrap up, we encourage our listeners to stay informed and proactive about their health, reminding them that they are not alone in this journey. Tune in for expert insights, valuable information, and a supportive community dedicated to your health and well-being.Let me know in the Comments section if you have specific topics you want me to cover.Don't forget about the download, which you can access from our podcast show on our website.Looking for more resources?CLICK HERE to visit our website to answer additional questions.CLICK HERE to access our blogs and sign-up for our newsletters.

Telix Pharmaceuticals have pulled out of a plan to list on the Nasdaq and will take on $650 million worth of debt. ASX200: down 0.09% to 7,963 AUD: 65.99 US cents GOLD: $2,413 USD/oz BITCOIN: $100,424 AUD There were mixed fortunes for Tesla & Alphabet in overnight reporting.  Gains were led by the gold miners, with Emerald Resources up 6%, Ramelius up 4.2% and Evolution up 4.1%. Gains of more than 1% for Cochlear, Suncorp and Resmed. It was a sell off for energy and real estate stocks driving the losses today. Falls in the oil price – with one barrel of Brent crude oil at $US 81 – saw losses of 1.3% for Ampol, Viva Energy down 1% and Beach Energy off by 3.3% Goodman Group and Stockland led the real estate losses, down 2.1 and 2% respectively. And Flight Centre shed 4.7% after revising its profit guidance. See omnystudio.com/listener for privacy information.

The American election has turned another corner, with Joe Biden dropping out of the race. But will that shift US markets at all? ASX200: down 0.50%, 7,931 AUD: 66.65 US cents GOLD: $2,405 US/oz BITCOIN: $100,903 AUD The Energy sector was the hardest hit, with only the Consumer Staples & Discretionary sectors escaping the falls. A 2.1% dive for Woodside after it made a $900 million US dollar move for an American LNG developer. Whitehaven dropped 4%, Beach fell 2.6%, while Karoon lost 2.1%. BHP fell 0.3%, and Fortescue dropped 0.5%, while South 32 plunged almost 13% after it sent a warning on the viability of the Worsley alumina refinery. Commonwealth was the sole major bank to escape the red.  Gains in the Staples sector saw Treasury Wines lift 1.9%, Coles up 1.3% and Endeavour rising 1.5% Insignia Financial jumped 5% to $2.50 as it said it expects better than expected earnings. While there were also gains of 1% or more for Cochlear, Yancoal and JB Hi-fi. See omnystudio.com/listener for privacy information.

Any otolaryngologist or cochlear implant (CI) patient can tell you that the journey to better hearing begins in earnest after CI activation. When the patient in question is a child, what does that journey look like? In this episode of the BackTable ENT podcast, Dr. Sarah Cordingley, audiologist with Peak ENT (Provo, Utah), joins host Dr. Gopi Shah to discuss aural rehabilitation for pediatric CI patients. --- SYNPOSIS First, Dr. Cordingley explains how audiologists work alongside otolaryngologists, social workers, and occupational therapists to prepare patients for cochlear implantation. Since younger patients cannot sit for a standard audiogram, she uses auditory milestones, visual reinforcement audiology (VRA) and conditioned play audiometry (CPA) to assess pediatric hearing loss. Then, she explains how audiologists help patients learn to use their implant, underscoring the importance of regular use, streaming, and participation in structured aural rehabilitation programs. The podcast concludes with a discussion of efforts to increase patient access to cochlear implants. --- TIMESTAMPS 00:00 - Welcome to the BackTable ENT Podcast 05:05 - Audiologists' Crucial Role in Cochlear Implant Evaluation 13:59 - Implant Activation & Programming 20:11 - The Importance of Family Support in Pediatric Hearing Loss 26:31 - Uses of Telehealth in Audiology 32:49 - Learning to Use New CI Technologies 41:47 - Equitable Access to Cochlear Implants 45:27 - Audiologists & Otolaryngologists: Partners for CI Success --- RESOURCES Dr. Cordingley's Peak ENT Profile: https://peakent.com/our-healthcare-providers/ Dr. Cordingley's email: scordingley@peakent.com

Outline00:00 - Intro01:17 - Early Years04:17 - The “Scenic Route” to Control Theory12:44 - Sampled Data Systems22:26 - Linear Parameter Varying (LPV) Identification28:07 - From Distributed Systems and PDEs ...38:59 - ... to Distributed Control of Spatially Invariant Systems49:02 - Taming the Navier-Stokes Equations50:55 - Advice to Future Students1:13:12 - Coherence in Large Scale Systems1:32:28 - On Resistive Losses in Power Systems1:39:00 - Cochlear Instabilities1:50:40 - Stochasticity in Feedback Loops2:00:00 - About Linear and Nonlinear Control2:08:14 - How to Select a Research Problem2:14:21 - Future of Control2:22:06 - OutroLinks- Paper on moment-invariants and object recognition: https://tinyurl.com/26tnks3z- Bassam's PhD Thesis: https://tinyurl.com/3n2274dv- Identification of linear parametrically varying systems: https://tinyurl.com/mryebhhy- Distributed control of spatially invariant systems: https://tinyurl.com/rzszjch2- Shift Operator: https://tinyurl.com/24fwehet- Heat Equation: https://tinyurl.com/57rc6s7h- Navier-Stokes Equations: https://tinyurl.com/45ktrd2e- The impulse response of the Navier-Stokes equations: https://tinyurl.com/4vaausfn- Non-Normal Matrix: https://tinyurl.com/58z4sph8- Coherence in large-scale networks: https://tinyurl.com/ynm5cbay- The Price of Synchrony: https://tinyurl.com/3svzancw- Tinnitus: https://tinyurl.com/yc5hm549- Cochlear Instabilities: https://tinyurl.com/fjespjbj- Stochasticity in Feedback Loops: https://tinyurl.com/yc6aw9xt- Koopman Operator: https://tinyurl.com/3jeu68p8- Carleman Linearization: https://tinyurl.com/yckzrnfh- Mamba Model: https://tinyurl.com/33h59jwj- Spectral Factorization: https://Support the Show.Podcast infoPodcast website: https://www.incontrolpodcast.com/Apple Podcasts: https://tinyurl.com/5n84j85jSpotify: https://tinyurl.com/4rwztj3cRSS: https://tinyurl.com/yc2fcv4yYoutube: https://tinyurl.com/bdbvhsj6Facebook: https://tinyurl.com/3z24yr43Twitter: https://twitter.com/IncontrolPInstagram: https://tinyurl.com/35cu4kr4Acknowledgments and sponsorsThis episode was supported by the National Centre of Competence in Research on «Dependable, ubiquitous automation» and the IFAC Activity fund. The podcast benefits from the help of an incredibly talented and passionate team. Special thanks to L. Seward, E. Cahard, F. Banis, F. Dörfler, J. Lygeros, ETH studio and mirrorlake . Music was composed by A New Element.

We're back for the latest episode of Buy or Sell.In today's episode, Adam Keily is joined by Scott Phillips of The Motley Fool.Get involved:Do you have a stock you want to ask about? Hit us up via our website. Track previous Buy or Sell picks on our website tracker—------In the spirit of reconciliation, Equity Mates Media and the hosts of Equity Mates Investing acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people today. —------Equity Mates Investing is a product of Equity Mates Media. This podcast is intended for education and entertainment purposes. Any advice is general advice only, and has not taken into account your personal financial circumstances, needs or objectives. Before acting on general advice, you should consider if it is relevant to your needs and read the relevant Product Disclosure Statement. And if you are unsure, please speak to a financial professional. Equity Mates Media operates under Australian Financial Services Licence 540697. Hosted on Acast. See acast.com/privacy for more information.

In this episode of the Future of Field Service podcast, host Sarah Nicastro is joined by Daniel Trabel, Director of Field Service EMEA at Thermo Fisher Scientific, to share the success his organization has had in bringing more women into field service roles and why he feels those who ignore the need to take action to improve diversity will fail. Daniel is a committed and visionary leader in service with a proven track record in the clinical diagnostics, life science, medical device, and biotechnology sectors. Before joining Thermo Fisher Scientific, he served as a Service Manager at Germany South for Waters Corporation, a Service Engineer at Cochlear, and held multiple roles at Bio-Rad Laboratories. If you enjoyed this episode, make sure to subscribe, rate, and review on Apple Podcasts, Spotify, and Google Podcasts. Also, subscribe to our newsletter right here: https://www.futureoffieldservice.com/articles

Earnings season is in full swing and we cover a number of companies that have caught our eye: Commonwealth Bank, A2 Milk, Cochlear, Lionstown, Domino's Pizza, Cettire & more.After that we speak to James from the Equity Mates community who has been keeping a close eye on New Zealand dairy player Synlait Milk. Links mentioned:2024 Community SurveyVideo of OpenAI's new text-to-video product SoraEquity Mates Facebook Discussion GroupBen Thompson's thoughts on Apple's Vision Pro (scroll about halfway down)—------Want to keep learning? Check out the Rask + Equity Mates investing courses. We've worked with the team at Rask Invest to produce two great investing courses:Get Started Investing is a free course that covers all the basics of investing and how to start building your portfolioThe Value Investor Program goes deep into stock selection and valuation. For a limited time, we're offering $100 off the Value Investor Program with the code: MATES. —------In the spirit of reconciliation, Equity Mates Media and the hosts of Equity Mates Investing acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people today. —------Equity Mates Investing is a product of Equity Mates Media. This podcast is intended for education and entertainment purposes. Any advice is general advice only, and has not taken into account your personal financial circumstances, needs or objectives. Before acting on general advice, you should consider if it is relevant to your needs and read the relevant Product Disclosure Statement. And if you are unsure, please speak to a financial professional. Equity Mates Media operates under Australian Financial Services Licence 540697. Hosted on Acast. See acast.com/privacy for more information.

Bendigo and Adelaide Bank CEO Marnie Baker speaks with SBS Finance Editor Ricardo Gonçalves about the economic outlook and why 41 per cent of her borrowers are at least one year ahead on their mortgage repayments, plus Cochlear Dig Howitt on the rise in Cochlear implant awareness, and hear from Stockopedia's Elio D'Amato about the day's market action.

Dr. Michal Kaufman, head of the Ear Surgery and Cochlear Transplantation Center at Hadassah Hospital Ein Kerem, talks us through the causes and treatments of hearing loss. 

שינוי בתקינה הוליד קטגוריה חדשה בשוק האוזניות שנועדה עבור אלו המתקשים לשמוע אבל לא מספיק כדי להצדיק מכשיר שמיעה יקר   שאלנו את בארד, מקווה שהוא לא מחרטט אבל זה מסתדר עם מה שידענו (שלזה יש שם ספציפי, משהו Bias) בכל מקרה, לפי המכון האמריקאי הלאומי לחרשות והפרעות תקשורת, יש בארה"ב כ-30 מיליון בוגרים עם אובדן שמיעה בשתי האוזניים, מתוכם רק 20% נחשבים חירשים, כלומר קשה להם להבין דיבור גם עם מכשיר שמיעה. שאר שמונים האחוזים נחשבים כבדי שמיעה, כך שמכשיר שמיעה יכול לעזור להם להבין דיבור. ופה בדיוק השוק של ה-iQ Buds 2 Max According to the National Institute on Deafness and Other Communication Disorders (NIDCD), approximately 30 million adults in the United States (13%) have hearing loss in both ears. Of these, 20% are considered deaf, meaning they have difficulty understanding speech even with a hearing aid. The remaining 80% are considered hard of hearing, meaning they can understand speech with the help of a hearing aid.   The prevalence of hearing loss increases with age. For example, about 40% of adults aged 65-74 and 70% of adults aged 75 and older have hearing loss in both ears.   Hearing loss can have a significant impact on a person's quality of life. It can make it difficult to communicate, participate in social activities, and work. It can also lead to social isolation, depression, and anxiety.   There are a number of things that can be done to help people with hearing loss, including: Wearing hearing aids. Hearing aids amplify sound, making it easier for people with hearing loss to hear. Cochlear implants. Cochlear implants are electronic devices that can restore some hearing to people who are profoundly deaf. American Sign Language (ASL). ASL is a visual language that is used by many deaf people. Learning ASL can help people with hearing loss communicate with others. Support groups. Support groups can provide people with hearing loss with a sense of community and understanding.   Of the 80% of adults in the US who are hard of hearing, 60% have light hearing loss and 40% have heavy hearing loss.   Light hearing loss is defined as a hearing loss of 25 to 40 decibels (dB). This level of hearing loss can make it difficult to hear soft sounds, such as a whisper or the ticking of a clock. However, people with light hearing loss can usually understand speech in quiet environments. Heavy hearing loss is defined as a hearing loss of 41 to 90 dB. This level of hearing loss can make it difficult to hear even loud sounds. People with heavy hearing loss may need to use a hearing aid or cochlear implant to understand speech. It is important to note that these are just general guidelines. The severity of hearing loss can vary from person to person, even if they have the same level of hearing loss. For example, two people with 40 dB of hearing loss may have different experiences. One person may be able to understand speech in quiet environments without any difficulty, while the other person may need to use a hearing aid to understand speech in any environment.

At age 10, Rachel Zemach lost her her hearing in an accident.  That obviously changed her life--but, she says, becoming deaf was one of her life's greatest gifts.  In this episode, Rachel shares her experiences going through the world with and without hearing, and offers advice on how hearing people can help and advocate for deaf people (including words and actions both to use and to avoid--hint: don't assume all deaf people can lip read!).  Rachel also offers her opinions about cochlear implants; teaching deaf kids and their parents American Sign Language; the strength and humor of the deaf community; and much more.  She spent many years as a teacher of deaf children, and recently wrote a book, "The Butterfly Cage," chronicling her experiences and observations.   In this episode:03:37--Describing coming home from the hospital at age 10 and realizing things were different05:13--How and why Rachel's love and language stayed strong07:21--Some of the "great gifts" she has experienced being part of the deaf community10:49--Frustrations and challenges Rachel faces14:31--Cochlear implants: what they are, how Rachel feels about them, and the benefits of learning ASL20:47--Why many doctors tell parents of deaf children not to learn ASL, and the harm that causes26:01--Rachel's thoughts on the state of advocacy for deaf people30:26-Rachel's advice to parents of deaf children31:25--The experience of writing a book about her years teaching deaf children33:42--Tips on things hearing people should (and should not) do and say to deaf peopleWant to know more about Rachel?Find her on Facebook: https://www.facebook.com/RzemachLink up with her on LinkedIn: https://www.linkedin.com/in/rachel-zemach/Tweet her on X/Twitter: https://twitter.com/rachel_zemachSearch up her website: www.rachelzemach.comBuy her book, The Butterfly Cage, at www.bookshop.orgWant to know more about "What It's Like To..."?Sign up to be on our Insiders' List to receive our newsletters and insiders' information! Go to whatitsliketo.net (sign-ups are at the bottom of the page)Follow us on social media:InstagramFacebookTwitterLinkedInSupport the show

This week, Helen talks to musician and author James Sills about how singing can be used to create connection in teams. Together they explore the insights in James' book 'Do Sing' and his experiences of working with teams all over the world. As part of Amazing If's 'teach a team to sing' campaign, at the end of the episode you'll also hear a squiggly sing-a-long with the Sales team at Cochlear. More ways to learn about Squiggly Careers:1.Sign up for our Squiggly Careers Skills Sprint: https://bit.ly/scskills-sprint 2.Download our Squiggly Careers PodBook: https://rb.gy/orb0n53. Sign-up for PodMail, a weekly summary of the latest squiggly career tools https://rb.gy/2xyo8i4. Read our books 'The Squiggly Career' and 'You Coach You' https://www.amazingif.com/books/If you have any questions or feedback (which we love!) you can email us at helenandsarah@squigglycareers.com Hosted on Acast. See acast.com/privacy for more information.

What would you do if you suddenly lost your hearing? Sami Rigby, an Australian advocate and someone who knows this question all too intimately, joins us for an enlightening conversation on managing Meniere's Disease and her experience getting a Cochlear implant. Sami takes us through her personal journey, sharing how she moved from a moderate to severe hearing loss amidst the COVID-19 lockdown, the emotional toll it took and how she discovered the power of self-care and the courage to prioritize her needs.Isn't it fascinating how the brain adapts to new challenges? Sammy's experience with her Cochlear implant goes beyond just a medical device, it's about the brain merging the sounds from the implant with natural hearing - a process Sami describes with vivid detail. From initially sounding robotic to gradually resembling someone speaking through a microphone, she shares the strategies she uses in noisy environments and the importance of shifting mindsets in social situations. It's an account that not only demystifies the Cochlear implant but also gives a voice to the Meniere's community.There's a special triumph in overcoming obstacles and reclaiming your life, and Sami's personal victories are a testament to that. She opens up about her acclimation process with the Cochlear implant, the tools that helped her along the way, and the importance of hearing protection. Her story is a beacon of hope, reminding us of the resilience of the human spirit, and how technology is transforming lives in the hearing loss community. Join us for this inspiring conversation that will leave you with a renewed appreciation for the everyday activities we often take for granted.Connect with Sami Rigby on Instagram: @deafjamsami  Support the showConnect with the Hearing Matters Podcast TeamEmail: hearingmatterspodcast@gmail.com Instagram: @hearing_matters_podcast Twitter: @hearing_mattasFacebook: Hearing Matters Podcast

Cochlear, the ASX-listed bionic ear company, reckons its profit to grow by double digits in this financial year. A major bid to buy Manchester United football club has failed because its majority owners just weren't happy with the price tag. Pfizer has announced that it will cut over $9 billion USD from its annual sales forecast after declining demand for Covid vaccines…and investors are kind of here for it. — We want your feedback - win 3 x $100 Uber Eats vouchers for your thoughts: https://fluxsurvey.typeform.com/to/qxN2pL4c Build the financial wellbeing of your team with Flux at Work: https://bit.ly/fluxatwork Download the free app (App Store): http://bit.ly/FluxAppStore Download the free app (Google Play): http://bit.ly/FluxappGooglePlay Daily newsletter: https://bit.ly/fluxnewsletter Flux on Instagram: http://bit.ly/fluxinsta Flux on TikTok: https://www.tiktok.com/@flux.finance —- The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.See omnystudio.com/listener for privacy information.

When people notice their vision blurring, they will frequently dash off to the eye doctor. Not so with hearing loss. It often goes ignored and undiagnosed until it becomes unbearable. Dr. Courtney Voelker is trying to change that. She's a neurotologist, a head and neck surgeon who specializes in diseases of the ear and related structures. She spends much of her time giving the gift of hearing to her patients using cochlear implants. These near-magical devices restore hearing after an intricate two-hour, outpatient surgery. They help newborns get on the path to mainstream development and cognition. Dr. Voelker has watched many toddlers light up when they hear the world for the first time. Cochlear implants help older adults avoid the isolation and cognitive decline that comes with hearing loss. With Bluetooth technology, cochlear implants are becoming almost bionic in their capabilities. They can connect to sound systems in music venues or classrooms. Listen to this episode to find out how Dr. Voelker is opening up access to the world of sound for all.

Hosted on Acast. See acast.com/privacy for more information.